January 2025 Tender Results
Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2024/25 Invitation to Tender dated 31 October 2024.
Some of the Pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of Pharmaceuticals that are subject to such contracts should continue to supply their Pharmaceutical under those contracts. Pharmac will continue to subsidise those Pharmaceuticals accordingly until such time as those Pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on the 12th of February 2025 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
Pharmac cannot list a product (and Pharmacies cannot claim) without this information. More information about this process, and a copy of the NOPC form can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). Pharmac cannot list a product (and Pharmacies cannot claim) without the correct Pharmacode.
- 31 January 2025 Tender Notification [PDF 290 KB]
2024/25 Tender – Principal Supply Status applies until 30 June 2028
Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule
The decisions were as follows:
1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
|---|---|---|---|---|---|---|
|
Adrenaline |
Inj 0.15 mg per 0.3 ml autoinjector; 1 Auto-injector pen OP |
$90.00 |
$85.50 |
EpiPen Jr (Viatris) |
1 July 2025 |
1 December 2025 |
|
Adrenaline |
Inj 0.3 mg per 0.3 ml autoinjector; 1 Auto-injector pen OP |
$90.00 |
$85.50 |
EpiPen (Viatris) |
1 July 2025 |
1 December 2025 |
|
Budesonide |
Cap modified-release 3 mg; 90 capsule bottle pack |
$87.60 |
$33.38 |
Budesonide Te Arai (Te Arai) |
1 July 2025 |
1 December 2025 |
|
Cetomacrogol with glycerol |
Crm 90% with glycerol 10%; 500 ml pump bottle OP |
$2.13 |
$1.92 |
Evara (Evara) |
1 July 2025 |
1 December 2025 |
|
Cetomacrogol with glycerol |
Crm 90% with glycerol 10%; 1,000 ml pump bottle OP |
$3.50 |
$3.25 |
Evara (Evara) |
1 July 2025 |
1 December 2025 |
|
Compound electrolytes |
Powder for oral soln; 50 sachet carton |
$9.53 |
$9.50 |
Electral (Teva) |
1 July 2025 |
1 December 2025 |
|
Domperidone |
Tab 10 mg; 100 tablet blister pack |
$4.00 |
$3.80 |
Domperidone Viatris (Viatris) |
1 July 2025 |
1 December 2025 |
|
Fludrocortisone acetate |
Tab 100 mcg; 100 tablet bottle pack |
$11.46 |
$8.05 |
Florinef (Aspen) |
1 July 2025 |
1 December 2025 |
|
Iloprost |
Nebuliser soln 10 mcg per ml, 2 ml; 30 glass ampoules |
$185.03 |
$166.53 |
Vebulis (Devatis) |
1 July 2025 |
1 December 2025 |
|
Mercaptopurine |
Tab 50 mg; 25 tablet bottle pack |
$25.90 |
$19.50 |
Puri-nethol (Aspen) |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 4 mg; 28 tablet blister pack |
$3.10 |
$3.10 |
Montelukast Viatris (Viatris) |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 5 mg; 28 tablet blister pack |
$3.10 |
$3.10 |
Montelukast Viatris (Viatris) |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 10 mg; 28 tablet blister pack |
$2.90 |
$2.45 |
Montelukast Viatris (Viatris) |
1 July 2025 |
1 December 2025 |
|
Ondansetron1 |
Tab 4 mg; 50 tablet blister pack |
$2.27 |
$1.95 |
Periset (Miro) |
1 July 2025 |
1 December 2025 |
|
Ondansetron1 |
Tab 8 mg; 50 tablet blister pack |
$4.10 |
$3.50 |
Periset (Miro) |
1 July 2025 |
1 December 2025 |
|
Posaconazole |
Oral liq 40 mg per ml; 105 ml bottle OP |
$342.51 |
$308.26 |
Devatis (Devatis) |
1 July 2025 |
1 December 2025 |
|
Posaconazole |
Tab modified release 100 mg; 24 tablet blister pack |
$206.00 |
$123.60 |
Posaconazole Juno (Arrotex) |
1 July 2025 |
1 December 2025 |
|
Pramipexole hydrochloride1 |
Tab 0.25 mg; 100 tablet blister pack |
$5.51 |
$5.23 |
Ramipex (Devatis) |
1 July 2025 |
1 December 2025 |
|
Pramipexole hydrochloride1 |
Tab 1 mg; 100 tablet blister pack |
$18.66 |
$17.73 |
Ramipex (Devatis) |
1 July 2025 |
1 December 2025 |
|
Tenofovir disoproxil |
Tab 245 mg (300 mg as a maleate); 30 tablet bottle pack |
$15.00 |
$13.80 |
Tenofovir Disoproxil Viatris (Viatris) |
1 July 2025 |
1 December 2025 |
|
Trimethoprim with sulphamethoxazole [co-trimoxazole] |
Oral liq 8 mg sulphamethoxazole 40 mg per ml, 100 ml bottle |
$5.00 |
$4.95 |
Deprim (AFT) |
1 March 2025 |
1 August 2025 |
|
Voriconazole |
Tab 50 mg; 56 tablet blister pack |
$91.00 |
$71.00 |
Vttack (Viatris) |
1 March 2025 |
1 August 2025 |
|
Voriconazole |
Tab 200 mg; 56 tablet blister pack |
$350.00 |
$263.00 |
Vttack (Viatris) |
1 March 2025 |
1 August 2025 |
|
1This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender. |
||||||
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
Listing date |
Principal Supply date |
Brand (Supplier) (Pharmacode) affected by delisting |
|---|---|---|---|---|---|---|---|
|
Promethazine hydrochloride |
Tab 10 mg; 100 tablet blister pack |
$1.39 (per 50) |
$2.19 |
Allersoothe (AFT) |
1 July 2025 |
1 December 2025 |
Allersoothe (AFT) (2238098) |
|
Promethazine hydrochloride |
Tab 25 mg; 100 tablet blister pack |
$1.58 (per 50) |
$2.69 |
Allersoothe (AFT) |
1 July 2025 |
1 December 2025 |
Allersoothe (AFT) (2238128) |
Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.
3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV Limit |
Listing date |
Principal Supply date |
|---|---|---|---|---|---|---|---|
|
Adrenaline |
Inj 0.15 mg per 0.3 ml autoinjector; 1 Auto-injector pen |
$90.00 |
$85.50 |
EpiPen Jr (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Adrenaline |
Inj 0.3 mg per 0.3 ml autoinjector; 1 Auto-injector pen |
$90.00 |
$85.50 |
EpiPen (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Budesonide |
Cap modified-release 3 mg; 90 capsule bottle pack |
$87.60 |
$33.38 |
Budesonide Te Arai (Te Arai) |
5% |
1 July 2025 |
1 December 2025 |
|
Bupivacaine hydrochloride with glucose |
Inj 0.5% with glucose 8%, 4 ml ampoule; 5 ampoule pack |
$26.67 |
$21.40 |
Marcain Heavy (Aspen) |
5% |
1 July 2025 |
1 December 2025 |
|
Cetomacrogol with glycerol |
Crm 90% with glycerol 10%; 500 ml pump bottle |
$2.13 |
$1.92 |
Evara (Evara) |
5% |
1 July 2025 |
1 December 2025 |
|
Cetomacrogol with glycerol |
Crm 90% with glycerol 10%; 1,000 ml pump bottle |
$3.50 |
$3.25 |
Evara (Evara) |
5% |
1 July 2025 |
1 December 2025 |
|
Compound electrolytes |
Powder for oral soln; 50 sachet carton |
$9.53 |
$9.50 |
Electral (Teva) |
5% |
1 July 2025 |
1 December 2025 |
|
Domperidone |
Tab 10 mg; 100 tablet blister pack |
$4.00 |
$3.80 |
Domperidone Viatris (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Fludrocortisone acetate |
Tab 100 mcg; 100 tablet bottle pack |
$11.46 |
$8.05 |
Florinef (Aspen) |
5% |
1 July 2025 |
1 December 2025 |
|
Iloprost |
Nebuliser soln 10 mcg per ml, 2 ml; 30 glass ampoules |
$185.03 |
$166.53 |
Vebulis (Devatis) |
5% |
1 July 2025 |
1 December 2025 |
|
Mercaptopurine |
Tab 50 mg; 25 tablet bottle pack |
$25.90 |
$19.50 |
Puri-nethol (Aspen) |
5% |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 4 mg; 28 tablet blister pack |
$3.10 |
$3.10 |
Montelukast Viatris (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 5 mg; 28 tablet blister pack |
$3.10 |
$3.10 |
Montelukast Viatris (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Montelukast |
Tab 10 mg; 28 tablet blister pack |
$2.90 |
$2.45 |
Montelukast Viatris (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Ondansetron2 |
Tab 4 mg; 50 tablet blister pack |
$2.27 |
$1.95 |
Periset (Miro) |
5% |
1 July 2025 |
1 December 2025 |
|
Ondansetron2 |
Tab 8 mg; 50 tablet blister pack |
$4.10 |
$3.50 |
Periset (Miro) |
5% |
1 July 2025 |
1 December 2025 |
|
Piperacillin with tazobactam |
Inj 4 g with tazobactam 0.5 g vial; 1 vial pack |
$3.59 |
$3.15 |
PipTaz-AFT (AFT) |
5% |
1 July 2025 |
1 December 2025 |
|
Posaconazole |
Oral liq 40 mg per ml; 105 ml bottle |
$342.51 |
$308.26 |
Devatis (Devatis) |
5% |
1 July 2025 |
1 December 2025 |
|
Posaconazole |
Tab modified release 100 mg; 24 tablet blister pack |
$206.00 |
$123.60 |
Posaconazole Juno (Arrotex) |
5% |
1 July 2025 |
1 December 2025 |
|
Pramipexole hydrochloride2 |
Tab 0.25 mg; 100 tablet blister pack |
$5.51 |
$5.23 |
Ramipex (Devatis) |
5% |
1 July 2025 |
1 December 2025 |
|
Pramipexole hydrochloride2 |
Tab 1 mg; 100 tablet blister pack |
$18.66 |
$17.73 |
Ramipex (Devatis) |
5% |
1 July 2025 |
1 December 2025 |
|
Tenofovir disoproxil |
Tab 245 mg (300 mg as a maleate); 30 tablet bottle pack |
$15.00 |
$13.80 |
Tenofovir Disoproxil Viatris (Viatris) |
5% |
1 July 2025 |
1 December 2025 |
|
Trimethoprim with sulphamethoxazole [co-trimoxazole] |
Oral liq 8 mg sulphamethoxazole 40 mg per ml, 100 ml bottle |
$5.00 |
$4.95 |
Deprim (AFT) |
5% |
1 March 2025 |
1 August 2025 |
|
Voriconazole |
Inj 200 mg vial; 1 vial pack |
$19.85 |
$16.89 |
AFT (AFT) |
5% |
1 July 2025 |
1 December 2025 |
|
Voriconazole |
Tab 50 mg; 56 tablet blister pack |
$91.00 |
$71.00 |
Vttack (Viatris) |
5% |
1 March 2025 |
1 August 2025 |
|
Voriconazole |
Tab 200 mg; 56 tablet blister pack |
$350.00 |
$263.00 |
Vttack (Viatris) |
5% |
1 March 2025 |
1 August 2025 |
|
2This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 4 clause 2.3(c)(ii) of the 2024/25 Invitation to Tender. |
|||||||
4. Tenders awarded to pharmaceuticals where at least one other brand is listed.
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV Limit |
Listing date |
Principal Supply date |
Brand (Supplier) (Pharmacode) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Promethazine hydrochloride |
Tab 10 mg; 100 tablet blister pack |
$1.39 (per 50) |
$2.19 |
Allersoothe (AFT) |
5% |
1 July 2025 |
1 December 2025 |
Allersoothe (AFT) (2238098) |
|
Promethazine hydrochloride |
Tab 25 mg; 100 tablet blister pack |
$1.58 (per 50) |
$2.69 |
Allersoothe (AFT) |
5% |
1 July 2025 |
1 December 2025 |
Allersoothe (AFT) (2238128) |
Tender declines – Products where no tender is to be awarded for Principal Supply Status
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2023/24 Invitation to Tender, dated 31 October 2023.
|
Chemical Name |
Line Item |
|---|---|
|
Disulfiram |
Tab 200 mg |
Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the 2024/25 Invitation to Tender, dated 31 October 2024.
|
Chemical Name |
Line Item |
|---|---|
|
Colestyramine |
Powder for oral liq 4 g |
|
Dipyridamole |
Tab or cap long-acting 150 mg |
|
Famotidine |
Inj 10 mg per ml, 2 ml |
|
Famotidine |
Inj 10 mg per ml, 4 ml |
|
Famotidine |
Tab 20 mg |
|
Famotidine |
Tab 40 mg |
|
Fludarabine phosphate |
Inj 50 mg |
|
Fludarabine phosphate |
Tab 10 mg |
|
Labetalol |
Tab 100 mg |
|
Labetalol |
Tab 200 mg |
|
Lithium carbonate |
Cap 250 mg |
|
Prazosin hydrochloride |
Tab 1 mg |
|
Prazosin hydrochloride |
Tab 2 mg |
|
Prazosin hydrochloride |
Tab 5 mg |
|
Preservative free ophthalmic |
Gel |
|
Sodium hypochlorite |
Soln 5% 1,000 – 2,500 ml |
For products included in the 2022/23, 2023/24 and 2024/25 Invitation to Tender where no announcement has yet been made, a decision is still pending subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.